scispace - formally typeset
M

Mario Petretta

Researcher at University of Naples Federico II

Publications -  264
Citations -  5705

Mario Petretta is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Coronary artery disease & Myocardial perfusion imaging. The author has an hindex of 36, co-authored 252 publications receiving 4908 citations.

Papers
More filters
Journal ArticleDOI

Traffic pollutants affect fertility in men

TL;DR: The finding that blood methaemoglobin and PB were inversely correlated with sperm parameters indicates that nitrogen oxide and Pb adversely affect semen quality.
Journal ArticleDOI

Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

TL;DR: Compared to patients with uncomplicated acromegaly, those with hypertension but without abnormalities of glucose tolerance had an increased prevalence of LV hypertrophy, and disease duration, circulating GH, and IGF-I levels were similar in the 2 groups.
Journal ArticleDOI

Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction.

TL;DR: This study supports the hypothesis that the renin-angiotensin system modulates the amplitude of ULF and VLF power and demonstrates that in MI patients, converting enzyme inhibition favorably modifies measures of heart period variability strongly associated with a poor prognosis.
Journal ArticleDOI

Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis

TL;DR: It was showed that statin therapy reduced the risk of CHD events in men without prior cardiovascular disease, but not in women, and statins did not reduce therisk of total mortality both in men and women.
Journal ArticleDOI

High Prevalence of Cardiac Valve Disease in Acromegaly: An Observational, Analytical, Case-Control Study

TL;DR: The persistence of valve disease in patients with cured acromegaly is likely to be correlated with the persistence of left ventricular hypertrophy, which should be carefully and continuously monitored as an aspect of the risk of cardiac dysfunction in these patients.